DALLAS, February 23, 2011 /PRNewswire/ -- The 'Global Top 10 Drug Delivery Technologies Market (2010 - 2015)' analyzes the drug delivery technologies market by the top 10 drug delivery technologies and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and ROW.
Browse market data tables and in-depth TOC on Global Top 10 Drug Delivery Technologies Market: Global Forecast.
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
Early buyers will receive 10% customization of reports.
The rising demand for effective delivery of novel biopharmaceuticals is driving the growth of the global top 10 drug delivery technologies market. Further, patent expirations of drugs is also boosting market growth. The global top 10 drug delivery technologies market is expected to grow from $43.8 billion in 2009 to $81.5 billion in 2015, at an estimated CAGR of 11% from 2010 to 2015. Prominent industry participants include Elan, Biovail, Nektar, Alkermes & Nektar.
Time release technologies account for the largest share around 10% of the top 10 drug delivery technologies market owing to the popularity of once daily formulations. Time release technologies market is expected to grow from US$8.5 billion in 2009 to Enormous opportunities lie in the area of unconventional technologies such as pulmonary, nasal and transdermal drug delivery due to technology innovations and expanded applications especially in chronic disease conditions.
Scope of the report
This research report categorizes the global market top 10 drug delivery technologies on the basis of their growth, therapeutic areas, patents registered, and industry focus. The report analyzes geography; forecasting revenues and trends in each of the following submarkets:
- Time release technologies - Targeted delivery - Aerosol technology - Encapsulation technology - Topical formulations - Injectables - Trandermal patch - Implant technology - Liposomal drug delivery - PEGlyation technology